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Article 7

Microbes, Men, and Animals

Dr. Charle11 Beruon (left) and Dr. Jon Palmer.
Unlike gregarious human beings, animals do
not hold conventions, and are therefore spared
the discomfort� and death, visited upon some
of the people who convened in Philadelphia in
1976. As you probably recall, this was the
infamous American Legion convention held at
the stately Bellevue Stratford hotel and the
disease outbreak brought about the demise of
a Philadelphla landmark. Naturally, the mal·
ady was quickly JabeUed "Legionaires Disease."
Subsequently, there have been some well pub·
licized outbreaks of this disease in other parts
of the world, and the causative organism has
been identified as Legion.ella pneumophilia.
It now appears that animals may be carri·
era of this organism, and Dr. Charles E. Ben·
son has begun a screening study to determine
whether this is true. Dr. Benson is associate
professor ot microbiology in the School of
Veterinary Medicine, whose laboratory is
located at New Bolton Center. Dr. Benson has
been involved in some basic studies on the
cbarac"teristics of L. pneumophilia which is an
organism that invades body cells. L. pneltl1W
philia itselr has never been isolated from
animals. but. antibodies, produced in response
to the organism, have been detected. Dr. Ben
son•s work is concerned with direct isolation of
the bacterium, a difficult chore. The organism
can be isolated from human beings where it
causes an atypical pneumonia, and Dr. Benson
has it growing in cell culture in his laboratory.
Dr. Benson's quest for this organism in animals
is iUustrative of one of his basic philosophies,
to wit, "we only find what we look for." Des·
pite some great strides, Dr. Benson points out
that we are still on the frontier in our efforts
to specifically identify bacteria that cause
many iniectious diseases in animals. There are
a number of clinical syndromes in animals "that
appear to be of an infectious nature, but for
which a causative organism has not been iden·
tilled. With this in mind, Dr. Benson and var
ious clinicians at New Bohon Center have
teamed together in the hope of gaining a bet·
ter understanding of the pathogenesis of cer·
tain of these perplexing syndromes. The clini
cians with whom he has been working most
closely are Dr. Robert Whitlock, Dr. Robert
Dyer, and Dr. Jon Palmer. Prior to Dr. Ben·
son's arrival at New Bolton Center in January
1961, this sort of cooperative effort in the
study of infectious diseases had been ne·
glected. Dr. Whitlock, who is associate
professor of medicine and chief of medical
services at New Bolton Center is quite enthu
siastic about the future of this field.
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Another major research interest of Dr. Ben·
son is the study of the organism, Salmonella.
This is a pathogen th
. at has long been the
plague of animals and humans. Interestingly, it
was first discovered by a veterinarian, Dr.
DarueJ E. Salmon, who was the first Chief of
the Federal Bureau of Animal Industry. One
problem in any study of Salmonella is that
there are over 1,200 strains of t.he organism.
WhiJe certain strains have been identified as
the cause of the disease in animals known as
salmone1Josis, it is possible that other, uniderr
tified strains may also be involved. One of the
objects of Dr. Ben11on's work will be to attempt
to define mechanisms of pathogenesis. The
particular strain now most commonly asso
ciated with colitis in horses is Salmonella
typhimurium. The common clinical signs are
hyperthennia, diarrhea, co.bcy pain, and occa
sionally a rapidly developing septicemia. One
characteristic of equine salmonellosis is that it
strikes horses that are in stressful situations,
includjng transport, weaning, worming, or any
other situation that lowers resistance. Surgery
may predispose horses to salmonellosis, and
one aspect of the work of Dra. Benson and
Palmer is to examine horses post-surgically for
the presence of Salmonella. Salmonellosis is
highly contagious at the local level; it can
become entrenc.�hed on a particular farm.
Horses with salmonellosis at New Bolton Cen·
ter are placed in isolation.
Dr. Benson states that some SalmoneUa
strains have the capability of producing to.x.im.
This is related to the genetic make-up of a
particular organism. Honles with toxemia.
associated with salmonellosis, have been
observed at New &Lton Center, and the se.a.r.:h
£or strains that produce this phenomena will
be part of the Benson/Palmer study.
In the past ten years there has been an
increase in the incidence of Salmonella infec·
tions in both humans and animals. Recently
there have been outbreaks of the disease in
humans foJJowing t.he consumption of cooked
beef. One problem in the spread of salmonel
losis is the fact that most species, including
humans, can act tLs carriers of the bacteria
without exhibiting overt clinical signs. It is
estimated that at least ten percent of the horse
population are carriers of Salmonella.
Diagnosis of salmonellosis is based upon
identification of or�anisms in fecal culture.
This may he difficult in carrier animals, and
Dr. Beru;on hopes to improve diagnostic
methods.
A cooperative study in which Dr. Benson is
involved witb Dr. Dyer, concerns the etiology
of "shipping fever,. in cattle and horses. Dr.
Benson is also conducting basic research on
metaboli� pathways in Salmonella and other
organisms. While he is relatively new to the
faculty of the School of Veterinary Medicine,
Dr. Benson has been at the University of Penn·
sylvania since 1975, with the School of Allied
Medical Professions. In addition to research he
teaches in the core and elective portions of the
veterinary curriculum, and is administrator of
the clinical laboratory at New Bolton Center.

Canine
Epilepsy
Epilepsy is one of the most common canine
neurological complaints, yet control of sei
zures in dogs remains a difficult, frustrating,
and often unrewarding task for veterinarian,
owner, and patient. In an effort to remedy
this situation. t••e Vetednary Hospital of the
University of Pennsylvania has recently insti·
tuted an epilepsy foundation for dogs called
the Canine Epilepsy Service under the direc·
torship of Or. George C. Farnbach, V.M.D.,
Ph.D., assi�tant professor of neurology. This
canine epilepsy center has the ambitious
goals of improving the control of seizures iu
epileptic dogs and, if possible, eliminating
seizures altogether through a cooperative
effort involving pets, their owners, their
locaJ veterinarians. and the facilities of the
Canine Epilepsy Service (CES).
Dogs, like people, suffer from epilepsy of
varying inten5ities and types. Like the physi
cian, a veterinarian is generally forced to
attempt to control epilepsy through the use
of anticonvulsant drugs. The control of seiz
ures in humans is tnore often successful than
it is in dogs because considerably more
information about the use and effectiveness
of anticonvulsant drugs in humans is avail
able to the physician. The process of control
ling human �:�ei.zures has been considerably
advanced by the study of large numbers of
epileptic patients on a variety of treatment
regimens, which was made possible by cen·
tralized epilepsy study groups. These groups
have deveJoped a wealth of knowledge about
the efficacy of $pecHic drugs, the blood levels
required to control seizures. and the toxic
and long-term effects of these drugs. Modern
technology now permi1s relatively inexpen
sive monitoring of serum drug leve]s, ena·
bling the physician to adjust or switch anti·
convulsants for maximum effect and
minimum toxicity baAed on the knowledge of
each drug and the individual patient's blood
levels. No such body of knowledge exists in
veterinary medicine, leaving the practitioner
to determine the appropriate anticonvulsant
for the patient on a limited and basically
blind triaJ-and-error basis. This can be a
costly and frustrating process.
"There are a variety of drugs and drug
combinations which can be used in control
protocols, yet accurate information about the
effecti\•e and toxic blood levels of these
drugs or about their long-term side effects in
the dog does not exist,.. Farnbach explained.
�At the CES we hope to collect this kind of
information over u Lon� period of time. Our
goal is to monitor at least 1,000 dogs for at
least three yearM."
To illustrate the importance of drug
information, F'arnbach cited Dilantin, a drug
commonly used in both humans and dogs to
control seizures. uln humans, DiJantin is
effective in many patients, but to control
seizures, blood levels above 10 ug/ml are
required. An effective dose for an adult
human is about 300 mg/day. We do not know

��nyone with a loved one-pet or human-that suffers
from epilepsy has serious medical and emotional problems
to face . Ira the past, we (the reterinarian and pet owners)
hat.'e faced thern alone and basically in the dark. If we can
get together both people and information we tvill not be
alone and� hopefully, the future will be brighter."
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if Dilantin is effective in the dog, but we do
know that the dog metaboli2les Dilantin
about 10 times faster than humans. In over
100 serum diJantin assays sent in from epi
leptic dogs, none showed more Dilantin than
7.2 ug/ml and none of the dogs were con
trolled. Three hundred mg/day might he an
effective dose for a small dog like a Chihua·
bua, but a German Shepherd would need
about 3,000 mg/day to reach 10 ug/ml in its
blood. And we don't know yet whether that
would be effective."
In humans, where effective blood levels
of Dilantin are known and patient blood lev
els can be monitored, the daily dosage can
easily be adjusted to fit the metabolic char
acteristics of each individual patient. If a
human patient has adequate blood levels of
Dilantin but continues to seizure, it becomes
immediately clear that a new drug and not a
new dose should be tried. The veterinarian
however, without blood level measurements,
must arbitnrily decide when to stop increas
ing dosages and change to or add different
drugs. To improve the techniques in veteri
nary seizure control. the Epilepsy Service
utilizes information collected from three
sources: 1) the pet owner, 2) the local veteri
narian, and 3) the routine monitoring of
blood levels of anticonvulsant medications in
epileptic animals.

A computer-based data management facil
ity has been established to carefully record
and monitor each patient. Initial informa·
tion about each patient is recorded as their
names are sent to the registry by the local
veterinarian. Pet owners are sent explanatory
litemture and forms to a·ecord the character
istics of each subsequent seizure. These
forms are filled in as seizures occur and are
mailed to the CES in order to monitor both
frequency and severity of each pet•s seizure
pattern. When an anticonvulsant drug pro
tocol is started by the local veterinarian, the
name of the drug or drugs and their dosages
and blood samples are sent to the CES. The
name and dosage of each drug and the cor·
responding serum level is added to the data
base for each individual patient. In this way,
changes in seizure patterns (or Lack thereof)
can be correlated with serum drug levels and
dose patterns in hundreds of individual
animals and the efficacy and toxicity of drug
protocols can be evaluated.
The computerized data management sys·
tern has been developed by Dr. Farnbach
specifically for the CES. Drug level mea·
surements ue made nsing the EMIT system
which has been validated for use with dog
serum by the SYVA Co. of Palo Alto, CA in
conjunction with the Canine Epilepsy Ser·
vice. This system represents a technological
advance which has proven advantageous in
monitoring human anticon,·ulsant therapy
and which will be cost-effective in monitor
ing veterinary anticonvulsant therapy.
''Computers and high technology are not
the answer," Farnbach emphasized...What is
needed is a massive cooperative effort
between animal lovers, veterinarians and
research workers. Anyone with a loved one
pet or human-that suffers from epilepsy has
serious medical and emotional problems to
face. In the past, we (the veterinarians and
pet owners) have faced them alone and basi
cally in the dark. If we can get together both
people and information we will not be alone
and, hopefully, the future will be brighter."
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Owners of epileptic dogs are a very
important part of the program. They not
only provide the veterinarian with the initial
information but they also provide the CES
with continuing information about the dog
and its improvement or the nature and fre·
quency of recurring seizures. The CES pro
vides mote than record keeping for the
owner. It provides support and information
and answers questions on both an individual
basis and through a Newsletter which will he
published shortly. In this way owners can see
that they are not alone and that their pet's
pTOblems are not unique. Further, the ques
tions and observations of the owners may
provide clues about seizure patterns and
triggers wtllch may have been previously
missed and ignored.
Participating veterinarians. also play an
obviously important role. Their observations
regarding efficacy, toxicity and long·term side
effects are essential to the development of
more rational drug protocols. In return for
their participation, veterinarians receive sev·
eral benefits: serum drug leve] measurements
are provided inexpensively; each animaPs
seizure and drug history is immediately
avaHable by computer for consultation with
the staff of CES, if they desire; and new con·
cepts regarding seizure control are dissemi·
nated as soon as thev are extracted from the
·
collected re<'.orda of all dogs in the program.
A Veterinary Newsletter is also being pub
lished for professional members of the
Canine Epilepsy Service.
The services of the Canine Epilepsy Ser
vice are available to aiJ pet owners free of
charge. Veterinarians are asked to make a
small annual contribution to cover the costs
of publications and computer maintenance.
Serum drug level measurements are provided
at cost for member veterinarians. The medi·
cal data (but not the personal data) are
available to any legitimate research organiza
tion wishing to use them in medical research.
Those interested in more detailed informa
tion or in. contributing to the program
should contact George C. Farnbach, V.M.D.,
Ph.D., Director, Canine Epilepsy Service,
School of Veterinary Medicine, University of
Pennsylvania, 3800 Spruce Street, Philadel
phia, Pa. 19104.

